Literature DB >> 18652541

Degradation products of extracellular matrix affect cell migration and proliferation.

Janet E Reing1, Li Zhang, Julie Myers-Irvin, Kevin E Cordero, Donald O Freytes, Ellen Heber-Katz, Khamilia Bedelbaeva, Donna McIntosh, Abiche Dewilde, Susan J Braunhut, Stephen F Badylak.   

Abstract

Biologic scaffolds composed of extracellular matrix (ECM) are utilized in numerous regenerative medicine applications to facilitate the constructive remodeling of tissues and organs. The mechanisms by which the host remodeling response occurs are not fully understood, but recent studies suggest that both constituent growth factors and biologically active degradation products derived from ECM play important roles. The objective of the present study was to determine if degradation of ECM scaffold materials in vitro by methods that are biochemically and physiologically relevant can yield products that possess chemotactic and/or mitogenic activities for fully differentiated mammalian endothelial cells and undifferentiated multipotential progenitor cells. ECM harvested from porcine urinary bladder was degraded enzymatically with pepsin/hydrochloric acid or papain. The ECM degradation products were tested for chemoattractant properties utilizing either 48-well chemotaxis filter migration microchambers or fluorescence-based filter migration assays, and were tested for mitogenic properties in cell proliferation assays. Results showed that ECM degradation products possessed chemotactic and mitogenic activities for multipotential progenitor cells and that the same degradation products inhibited both chemotaxis and proliferation of differentiated endothelial cells. These findings support the concept that degradation products of ECM bioscaffolds are important modulators of the recruitment and proliferation of appropriate cell types during the process of ECM scaffold remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18652541     DOI: 10.1089/ten.tea.2007.0425

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  121 in total

1.  Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model.

Authors:  Jessica A DeQuach; Joy E Lin; Cynthia Cam; Diane Hu; Michael A Salvatore; Farah Sheikh; Karen L Christman
Journal:  Eur Cell Mater       Date:  2012-06-05       Impact factor: 3.942

2.  Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials.

Authors:  Bryan N Brown; Ricardo Londono; Stephen Tottey; Li Zhang; Kathryn A Kukla; Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak
Journal:  Acta Biomater       Date:  2011-12-02       Impact factor: 8.947

3.  Right ventricular outflow tract repair with a cardiac biologic scaffold.

Authors:  John M Wainwright; Ryotaro Hashizume; Kazuro L Fujimoto; Nathaniel T Remlinger; Colin Pesyna; William R Wagner; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Cells Tissues Organs       Date:  2011-10-24       Impact factor: 2.481

4.  Biologic scaffold composed of skeletal muscle extracellular matrix.

Authors:  Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak
Journal:  Biomaterials       Date:  2012-01-20       Impact factor: 12.479

5.  Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells.

Authors:  Stephen Tottey; Mirko Corselli; Eric M Jeffries; Ricardo Londono; Bruno Peault; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2010-09-06       Impact factor: 3.845

6.  Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix.

Authors:  Bryan N Brown; John M Freund; Li Han; J Peter Rubin; Janet E Reing; Eric M Jeffries; Mathew T Wolf; Stephen Tottey; Christopher A Barnes; Buddy D Ratner; Stephen F Badylak
Journal:  Tissue Eng Part C Methods       Date:  2011-02-05       Impact factor: 3.056

7.  Esophagus and regenerative medicine.

Authors:  Ricardo Londono; Blair A Jobe; Toshitaka Hoppo; Stephen F Badylak
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  Highly Aligned Nanofibrous Scaffold Derived from Decellularized Human Fibroblasts.

Authors:  Qi Xing; Caleb Vogt; Kam W Leong; Feng Zhao
Journal:  Adv Funct Mater       Date:  2014-05-28       Impact factor: 18.808

9.  Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells.

Authors:  Ellen P Brennan; Xiao-Han Tang; Ann M Stewart-Akers; Lorraine J Gudas; Stephen F Badylak
Journal:  J Tissue Eng Regen Med       Date:  2008-12       Impact factor: 3.963

10.  Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Authors:  Sonya B Seif-Naraghi; Jennifer M Singelyn; Michael A Salvatore; Kent G Osborn; Jean J Wang; Unatti Sampat; Oi Ling Kwan; G Monet Strachan; Jonathan Wong; Pamela J Schup-Magoffin; Rebecca L Braden; Kendra Bartels; Jessica A DeQuach; Mark Preul; Adam M Kinsey; Anthony N DeMaria; Nabil Dib; Karen L Christman
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.